Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension.
Masson B, Le Ribeuz H, Sabourin J, Laubry L, Woodhouse E, Foster R, Ruchon Y, Dutheil M, Boët A, Ghigna MR, De Montpreville VT, Mercier O, Beech DJ, Benitah JP, Bailey MA, Humbert M, Montani D, Capuano V, Antigny F. Masson B, et al. Circ Res. 2022 Oct 14;131(9):e102-e119. doi: 10.1161/CIRCRESAHA.122.321041. Epub 2022 Sep 27. Circ Res. 2022. PMID: 36164973 Free article.
Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension.
Masson B, Saint-Martin Willer A, Dutheil M, Penalva L, Le Ribeuz H, El Jekmek K, Ruchon Y, Cohen-Kaminsky S, Sabourin J, Humbert M, Mercier O, Montani D, Capuano V, Antigny F. Masson B, et al. Am J Physiol Lung Cell Mol Physiol. 2023 Aug 1;325(2):L246-L261. doi: 10.1152/ajplung.00011.2023. Epub 2023 Jun 27. Am J Physiol Lung Cell Mol Physiol. 2023. PMID: 37366608
SUR1 As a New Therapeutic Target for Pulmonary Arterial Hypertension.
Le Ribeuz H, Masson B, Capuano V, Dutheil M, Gooroochurn H, Boët A, Ghigna MR, De Montpreville V, Girerd B, Lambert M, Mercier O, Chung WK, Humbert M, Montani D, Antigny F. Le Ribeuz H, et al. Among authors: masson b. Am J Respir Cell Mol Biol. 2022 May;66(5):539-554. doi: 10.1165/rcmb.2021-0180OC. Am J Respir Cell Mol Biol. 2022. PMID: 35175177
Role of KCNK3 Dysfunction in Dasatinib-associated PAH and Endothelial Cell Dysfunction.
Le Ribeuz H, Saint-Martin Willer A, Chevalier B, Sancho M, Masson B, Eyries M, Jung V, Guerrera IC, Dutheil M, El Jekmek K, Laubry L, Carpentier G, Perez-Vizcaino F, Tu L, Guignabert C, Chaumais MC, Péchoux C, Humbert M, Hinzpeter A, Mercier O, Capuano V, Montani D, Antigny F. Le Ribeuz H, et al. Among authors: masson b. Am J Respir Cell Mol Biol. 2024 Mar 28. doi: 10.1165/rcmb.2023-0185OC. Online ahead of print. Am J Respir Cell Mol Biol. 2024. PMID: 38546978
Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure.
Hautbergue T, Antigny F, Boët A, Haddad F, Masson B, Lambert M, Delaporte A, Menager JB, Savale L, Pavec JL, Fadel E, Humbert M, Junot C, Fenaille F, Colsch B, Mercier O. Hautbergue T, et al. Among authors: masson b. Cells. 2021 Jun 21;10(6):1559. doi: 10.3390/cells10061559. Cells. 2021. PMID: 34205639 Free PMC article.
Involvement of SUR2/Kir6.1 channel in the physiopathology of pulmonary arterial hypertension.
Le Ribeuz H, Masson B, Dutheil M, Boët A, Beauvais A, Sabourin J, De Montpreville VT, Capuano V, Mercier O, Humbert M, Montani D, Antigny F. Le Ribeuz H, et al. Among authors: masson b. Front Cardiovasc Med. 2023 Jan 10;9:1066047. doi: 10.3389/fcvm.2022.1066047. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36704469 Free PMC article.